fasudil has been researched along with Dyslipidemia in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 7.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| "Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia." | 3.81 | Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z | 1 |
| Lian, H | 1 |
| Liang, Q | 1 |
| Zeng, F | 1 |
| Zheng, D | 1 |
1 other study available for fasudil and Dyslipidemia
| Article | Year |
|---|---|
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Drug Therapy, Combination; Dyslipidemias; Ma | 2015 |